抽象的な

The subsidized insurance act's healthcare reform and treatment for innocuous endocrine surgical ailments.

Eren Berberioely*

Although the effect of the Medicaid expansion under the Affordable Care Act on benign endocrine disease is unknown, it increased insurance coverage and access to care for endocrine cancers. From 2009 to 2016, benign thyroid, parathyroid, and adrenal disease patients had operations. In January 2014, the Vizient Clinical Data Base patients were compiled by state Medicaid expansion status. Difference-in-differences analysis was used to analyse insurance coverage, and logistic regression was used to assess the odds of an operation based on insurance status. There are still obstacles for Medicaid patients with parathyroid and adrenal disease despite the fact that the expansion of Medicaid increased insurance coverage for benign endocrine disease.